Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease
Shu Dong, Zong-Ying Zhan, Hongyan Cao, et al.
World Journal of Gastroenterology (2017) Vol. 23, Iss. 15, pp. 2771-2771
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Metabolomics for Investigating Physiological and Pathophysiological Processes
David S. Wishart
Physiological Reviews (2019) Vol. 99, Iss. 4, pp. 1819-1875
Open Access | Times Cited: 748
Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease
Huikuan Chu, Yi Duan, Ling Yang, et al.
Gut (2018) Vol. 68, Iss. 2, pp. 359-370
Open Access | Times Cited: 304
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
Mojgan Masoodi, Amalia Gastaldelli, Tuulia Hyötyläinen, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 12, pp. 835-856
Closed Access | Times Cited: 301
Metabolomics biotechnology, applications, and future trends: a systematic review
Qiang Yang, Aihua Zhang, Jianhua Miao, et al.
RSC Advances (2019) Vol. 9, Iss. 64, pp. 37245-37257
Open Access | Times Cited: 137
The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease
Nikolaos Perakakis, Konstantinos Stefanakis, Christos S. Mantzoros
Metabolism (2020) Vol. 111, pp. 154320-154320
Open Access | Times Cited: 119
Effects of exercise on NAFLD using non-targeted metabolomics in adipose tissue, plasma, urine, and stool
Ambrin Farizah Babu, Susanne Csader, Ville Männistö, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 48
Identification of Gut Microbial Lysine and Histidine Degradation and CYP-Dependent Metabolites as Biomarkers of Fatty Liver Disease
Anastasiia Driuchina, Jukka Hintikka, Marko Lehtonen, et al.
mBio (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Biomarkers for Health Functional Foods in Metabolic Dysfunction-Associated Steatotic Liver Disorder (MASLD) Prevention: An Integrative Analysis of Network Pharmacology, Gut Microbiota, and Multi-Omics
Heng Yuan, Eun-Soo Jung, Soo-Wan Chae, et al.
Nutrients (2024) Vol. 16, Iss. 18, pp. 3061-3061
Open Access | Times Cited: 7
Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction
Da Jung Kim, Seonghae Yoon, Sang Chun Ji, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 74
Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy
Diren Beyoğlu, Jeffrey R. Idle
Metabolites (2020) Vol. 10, Iss. 2, pp. 50-50
Open Access | Times Cited: 68
The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD)
Dragana Savic, Leanne Hodson, Stefan Neubauer, et al.
Nutrients (2020) Vol. 12, Iss. 8, pp. 2178-2178
Open Access | Times Cited: 58
Cannabinoid-2 receptor depletion promotes non-alcoholic fatty liver disease in mice via disturbing gut microbiota and tryptophan metabolism
Weiting Cheng, Siya Pei, Jie Wu, et al.
Acta Pharmacologica Sinica (2025)
Open Access
Serum Metabolic Signatures and MetalnFF Diagnostic Score for Mild and Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease
Yang Chen, Y. Wang, Tuo Shen, et al.
Journal of Pharmaceutical and Biomedical Analysis (2025) Vol. 260, pp. 116772-116772
Closed Access
Targeting Human Urinary Metabolome by LC–MS/MS: A Review
José Rodríguez-Morató, Óscar J. Pozo, Josep Marcos
Bioanalysis (2018) Vol. 10, Iss. 7, pp. 489-516
Open Access | Times Cited: 47
An Organ-Specific Metabolite Annotation Approach for Ambient Mass Spectrometry Imaging Reveals Spatial Metabolic Alterations of a Whole Mouse Body
Ying Zhu, Qingce Zang, Zhigang Luo, et al.
Analytical Chemistry (2022) Vol. 94, Iss. 20, pp. 7286-7294
Closed Access | Times Cited: 22
Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical Perspectives
Stefano Gitto, Filippo Schepis, Pietro Andreoné, et al.
Metabolites (2018) Vol. 8, Iss. 1, pp. 17-17
Open Access | Times Cited: 39
Distinguishing NASH Histological Severity Using a Multiplatform Metabolomics Approach
George N. Ioannou, G. A. Nagana Gowda, Danijel Djukovic, et al.
Metabolites (2020) Vol. 10, Iss. 4, pp. 168-168
Open Access | Times Cited: 33
New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer
Niama Ezzaidi, Xiang Zhang, Olabisi Oluwabukola Coker, et al.
Cancer Letters (2019) Vol. 459, pp. 186-191
Closed Access | Times Cited: 32
Differentiation between stages of non-alcoholic fatty liver diseases using surface-enhanced Raman spectroscopy
Elisa Gurian, Pablo J. Giraudi, Natalia Rosso, et al.
Analytica Chimica Acta (2020) Vol. 1110, pp. 190-198
Closed Access | Times Cited: 28
Urine Metabolomics Analysis in Patients With Normoalbuminuric Diabetic Kidney Disease
Qian Feng, Yuanmeng Li, Yuwei Yang, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 27
Serum Bile Acid, Vitamin E, and Serotonin Metabolites Are Associated With Future Liver‐Related Events in Nonalcoholic Fatty Liver Disease
Kara Wegermann, Catherine Howe, Ricardo Henao, et al.
Hepatology Communications (2021) Vol. 5, Iss. 4, pp. 608-617
Open Access | Times Cited: 26
ASC, IL-18 and Galectin-3 as Biomarkers of Non-Alcoholic Steatohepatitis: A Proof of Concept Study
Brianna Cyr, Robert W. Keane, Juan Pablo de Rivero Vaccari
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8580-8580
Open Access | Times Cited: 25
Accurate non‐invasive diagnosis and staging of non‐alcoholic fatty liver disease using the urinary steroid metabolome
Ahmad Moolla, Jasper de Boer, David Pavlov, et al.
Alimentary Pharmacology & Therapeutics (2020) Vol. 51, Iss. 11, pp. 1188-1197
Open Access | Times Cited: 24
Metabolomic Hallmarks of Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease
Diren Beyoğlu, Yury Popov, Jeffrey R. Idle
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12809-12809
Open Access | Times Cited: 2
A metabolomic study on early detection of steroid-induced avascular necrosis of the femoral head
Xiangnan Ren, Wu Fan, Zixing Shao, et al.
Oncotarget (2018) Vol. 9, Iss. 8, pp. 7984-7995
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top